Advanced Therapy medicinal products for autologous chondrocytes and comparison of regulatory systems in target countries

INTRODUCTION: Autologous chondrocytes (ACs) are Human cell/tissue-based products used for the treatment of joint cartilage defects. Regulatory agencies have established regulations related to ACs to ensure their safety and efficacy. This study investigated the status and characteristics of ACs appro...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jiwon, Park, Jaehong, Song, Seung-Yeon, Kim, Eunyoung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japanese Society for Regenerative Medicine 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9079100/
https://www.ncbi.nlm.nih.gov/pubmed/35582708
http://dx.doi.org/10.1016/j.reth.2022.04.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9079100/
https://www.ncbi.nlm.nih.gov/pubmed/35582708
http://dx.doi.org/10.1016/j.reth.2022.04.004

Ejemplares similares